Clearside Biomedical (CLSD) Short Interest Ratio & Short Volume $0.86 -0.01 (-1.13%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$0.87 +0.01 (+0.93%) As of 04/17/2025 06:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Clearside Biomedical Short Interest DataClearside Biomedical (CLSD) has a short interest of 468,900 shares, representing 0.68% of the float (the number of shares available for trading by the public). This marks a -36.26% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.3, indicating that it would take 2.3 days of the average trading volume of 348,581 shares to cover all short positions.Current Short Interest468,900 sharesPrevious Short Interest735,600 sharesChange Vs. Previous Month-36.26%Dollar Volume Sold Short$430,403.31Short Interest Ratio2.3 Days to CoverLast Record DateMarch 31, 2025Outstanding Shares77,279,000 sharesShort Percent of Float0.68%Today's Trading Volume266,926 sharesAverage Trading Volume348,581 sharesToday's Volume Vs. Average77% Short Selling Clearside Biomedical? Sign up to receive the latest short interest report for Clearside Biomedical and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCLSD Short Interest Over TimeCLSD Days to Cover Over TimeCLSD Percentage of Float Shorted Over Time Clearside Biomedical Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/2025468,900 shares $430,403.31 -36.3%0.7%2.3 $0.92 3/15/2025735,600 shares $654,463.32 -4.1%1.1%3 $0.89 2/28/2025767,400 shares $659,733.78 +34.3%1.1%3 $0.86 2/15/2025571,300 shares $611,291.00 -26.6%0.8%2.3 $1.07 1/31/2025777,800 shares $723,354.00 +2.5%N/A3.1 $0.93 1/15/2025758,900 shares $713,366.00 +2.3%N/A2.7 $0.94 12/31/2024741,700 shares $704,615.00 -32.6%N/A1.1 $0.95 12/15/20241,100,000 shares $1.12 million -17.9%N/A1.5 $1.02 11/30/20241,340,000 shares $1.41 million -11.8%N/A1.8 $1.05 11/15/20241,520,000 shares $1.50 million -13.6%N/A2 $0.99 Get the Latest News and Ratings for CLSD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Clearside Biomedical and its competitors with MarketBeat's FREE daily newsletter. 10/31/20241,760,000 shares $1.80 million -9.7%N/A2.4 $1.02 10/15/20241,950,000 shares $2.16 million +646.6%N/A2.7 $1.11 9/30/2024261,200 shares $331,724.00 -4.5%N/A0.5 $1.27 9/15/2024273,400 shares $336,282.00 -18.4%N/A1.1 $1.23 8/31/2024335,200 shares $338,552.00 +86.0%N/A1.5 $1.01 8/15/2024180,200 shares $190,111.00 -12.9%N/A1.1 $1.06 7/31/2024206,900 shares $235,866.00 +76.8%N/A1.1 $1.14 7/15/2024117,000 shares $145,080.00 -48.4%N/A0.7 $1.24 6/30/2024226,900 shares $294,970.00 +17.5%N/A1.2 $1.30 6/15/2024193,100 shares $229,789.00 -30.0%N/A0.8 $1.19 5/31/2024275,800 shares $386,120.00 -19.7%N/A0.9 $1.40 5/15/2024343,300 shares $453,156.00 +1.4%N/A0.9 $1.32 4/30/2024338,700 shares $426,762.00 +27.7%N/A0.9 $1.26 4/15/2024265,300 shares $342,237.00 +18.3%N/A0.7 $1.29 3/31/2024224,300 shares $343,179.00 -34.0%N/A0.6 $1.53 3/15/2024339,900 shares $581,229.00 +23.4%N/A1 $1.71 2/29/2024275,400 shares $385,560.00 +70.1%N/A1 $1.40 2/15/2024161,900 shares $197,518.00 -12.0%N/A0.9 $1.22 1/31/2024183,900 shares $229,875.00 -12.8%0.4%1 $1.25 1/15/2024210,800 shares $305,660.00 +11.1%0.4%1.1 $1.45 12/31/2023189,700 shares $221,949.00 -43.8%0.4%1 $1.17 12/15/2023337,700 shares $347,831.00 +19.4%0.7%2.1 $1.03 11/30/2023282,900 shares $285,729.00 -3.4%0.6%2.3 $1.01 11/15/2023292,900 shares $281,184.00 +0.8%0.6%2.5 $0.96 10/31/2023290,600 shares $210,568.76 -15.7%0.6%2.3 $0.72 10/15/2023344,500 shares $296,614.50 -1.7%0.7%3.6 $0.86 9/30/2023350,500 shares $304,899.95 -8.5%0.7%3.3 $0.87 9/15/2023382,900 shares $315,892.50 +45.4%0.8%3.4 $0.83 8/31/2023263,400 shares $239,694.00 +20.2%0.5%2.1 $0.91 8/15/2023219,200 shares $217,008.00 -17.5%0.4%1.8 $0.99Something strange going on at Mar-a-Lago (Ad)A former government advisor says a $9 trillion AI breakthrough is nearing launch. It may become America’s biggest advantage in the race against China — and a handful of Musk-linked companies could benefit.Nvidia’s early days made millionaires. This AI play might too. 7/31/2023265,700 shares $310,869.00 -22.4%0.5%2.2 $1.17 7/15/2023342,400 shares $410,880.00 -17.4%0.7%2.7 $1.20 6/30/2023414,400 shares $464,128.00 -15.0%0.8%3.3 $1.12 6/15/2023487,600 shares $682,640.00 -22.1%1.0%2.9 $1.40 5/31/2023626,100 shares $676,188.00 +10.2%1.2%3.6 $1.08 5/15/2023568,400 shares $608,188.00 +102.8%1.1%3.1 $1.07 4/30/2023280,300 shares $283,103.00 +4.0%0.6%1.5 $1.01 4/15/2023269,600 shares $296,560.00 -19.6%0.5%1.3 $1.10 3/31/2023335,500 shares $348,920.00 -4.5%0.7%1.5 $1.04 3/15/2023351,200 shares $344,176.00 +8.7%0.7%1.5 $0.98 2/28/2023323,100 shares $400,644.00 +0.1%0.7%1.4 $1.24 2/15/2023322,700 shares $432,418.00 +30.5%0.7%1.3 $1.34 1/31/2023247,200 shares $348,552.00 +15.4%0.5%0.8 $1.41 1/15/2023214,300 shares $336,451.00 -48.3%0.4%0.8 $1.57 12/30/2022414,600 shares $464,352.00 +3.8%0.8%1.6 $1.12 12/15/2022399,500 shares $483,395.00 +5.9%0.8%1.8 $1.21 11/30/2022377,100 shares $456,291.00 -32.6%0.8%2 $1.21 11/15/2022559,600 shares $789,036.00 +4.8%1.2%3 $1.41 10/31/2022534,100 shares $608,874.00 +7.7%1.1%4.1 $1.14 10/15/2022495,800 shares $565,212.00 +4.8%1.0%3.9 $1.14 9/30/2022473,100 shares $534,603.00 -9.1%1.0%3.6 $1.13 9/15/2022520,300 shares $686,796.00 +11.0%1.1%3.8 $1.32 8/31/2022468,600 shares $641,982.00 +8.3%1.0%3.1 $1.37 8/15/2022432,700 shares $666,358.00 -7.0%0.9%2.8 $1.54 7/31/2022465,100 shares $716,254.00 -20.8%1.0%2.8 $1.54 7/15/2022587,100 shares $1.06 million -10.0%1.2%2.8 $1.81 6/30/2022652,100 shares $958,587.00 -30.9%1.4%2.8 $1.47 6/15/2022944,000 shares $1.26 million -24.5%2.0%3.6 $1.34 5/31/20221,250,000 shares $1.63 million -24.7%2.6%1.4 $1.30 5/15/20221,660,000 shares $2.34 million No Change3.4%1.7 $1.41 4/30/20221,660,000 shares $2.54 million -11.7%3.4%1.7 $1.53 4/15/20221,880,000 shares $3.91 million +36.2%3.9%1.8 $2.08 3/31/20221,380,000 shares $3.16 million -46.7%2.9%1.4 $2.29 3/15/20222,590,000 shares $6.45 million +102.3%5.4%2.5 $2.49 2/28/20221,280,000 shares $2.04 million -3.8%2.7%3 $1.60 2/15/20221,330,000 shares $2.26 million -7.0%2.8%3.1 $1.70 1/31/20221,430,000 shares $2.79 million +28.8%3.0%3.3 $1.95 1/15/20221,110,000 shares $2.48 million -9.0%N/A2.3 $2.23 12/31/20211,220,000 shares $3.36 million -3.2%2.6%2.6 $2.75 12/15/20211,260,000 shares $3.70 million +18.9%2.7%2.4 $2.94 11/30/20211,060,000 shares $3.89 million +1.0%2.2%2.1 $3.67 11/15/20211,050,000 shares $5.07 million -52.3%2.2%2 $4.83 10/29/20212,200,000 shares $12.01 million +81.8%4.6%4 $5.46 10/15/20211,210,000 shares $6.82 million +28.4%2.6%2.1 $5.64 9/30/2021942,500 shares $5.66 million -0.9%2.0%1.6 $6.00 9/15/2021951,200 shares $6.25 million -36.2%2.0%1 $6.57 8/31/20211,490,000 shares $10.27 million -32.6%3.2%0.5 $6.89 8/13/20212,210,000 shares $12.57 million +5.7%4.7%0.7 $5.69 7/30/20212,090,000 shares $10.28 million +11.2%4.7%0.7 $4.92 7/15/20211,880,000 shares $9.95 million +18.2%4.2%0.6 $5.29The U.S. just rewrote the rules of retirement (Ad)For decades, Wall Street told retirees to stick with big names, stay diversified, and live off dividends. But Tim Plaehn says those rules no longer apply — and the 2025 trade war is exposing just how fragile that plan really was. Tim just released a video briefing explaining how the global shift is hammering traditional income stocks — and how a few U.S.-focused companies are built to weather the chaos.Watch the 2025 Trade War dividend protection briefing now 6/30/20211,590,000 shares $7.74 million +43.2%3.6%0.5 $4.87 6/15/20211,110,000 shares $4.62 million +37.0%2.5%0.4 $4.16 5/28/2021810,500 shares $2.08 million -6.5%1.9%3.6 $2.57 5/14/2021866,500 shares $2.01 million -9.7%N/A3.2 $2.32 4/30/2021959,100 shares $2.86 million -0.6%N/A2.8 $2.98 4/15/2021965,200 shares $2.58 million +1.9%N/A2.3 $2.67 3/31/2021947,500 shares $2.22 million +44.3%N/A1.6 $2.34 3/15/2021656,600 shares $2.00 million +53.2%N/A0.8 $3.05 2/26/2021428,700 shares $1.39 million -16.9%N/A0.5 $3.25 2/12/2021515,600 shares $1.99 million +29.1%N/A0.6 $3.86 1/29/2021399,400 shares $1.32 million -37.9%N/A0.5 $3.31 1/15/2021643,600 shares $2.70 million -22.7%N/A0.9 $4.20 12/31/2020832,500 shares $1.93 million -16.7%N/A1.4 $2.32 12/15/2020999,700 shares $2.08 million -16.7%2.8%4.1 $2.08 11/30/20201,200,000 shares $2.34 million -12.4%3.3%6 $1.95 11/15/20201,370,000 shares $2.26 million -5.5%3.8%8.8 $1.65 10/30/20201,450,000 shares $2.03 million -0.7%4.2%7.9 $1.40 10/15/20201,460,000 shares $2.13 million -4.6%4.3%6.2 $1.46 9/30/20201,530,000 shares $2.36 million -8.4%4.5%5.7 $1.54 9/15/20201,670,000 shares $2.77 million +3.1%4.9%5.8 $1.66 8/31/20201,620,000 shares $2.79 million -10.5%4.7%4.7 $1.72 8/14/20201,810,000 shares $3.24 million +11.0%5.3%4.6 $1.79 7/31/20201,630,000 shares $2.67 million -1.8%4.8%4 $1.64 7/15/20201,660,000 shares $2.79 million +5.7%5.0%4.2 $1.68 6/30/20201,570,000 shares $2.95 million -0.6%4.7%3.8 $1.88 6/15/20201,580,000 shares $3.24 million +4.0%4.8%3.8 $2.05 5/29/20201,520,000 shares $2.83 million +2.0%4.6%3.2 $1.86 5/15/20201,490,000 shares $2.95 million -0.7%4.5%3 $1.98 4/30/20201,500,000 shares $2.97 million -10.2%4.5%2.9 $1.98 CLSD Short Interest - Frequently Asked Questions What is Clearside Biomedical's current short interest? Short interest is the volume of Clearside Biomedical shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 468,900 shares of CLSD short. 0.68% of Clearside Biomedical's shares are currently sold short. Learn More on Clearside Biomedical's current short interest. What is a good short interest ratio for Clearside Biomedical? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CLSD shares currently have a short interest ratio of 2.0. Learn More on Clearside Biomedical's short interest ratio. Which institutional investors are shorting Clearside Biomedical? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Clearside Biomedical: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Clearside Biomedical? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.68% of Clearside Biomedical's floating shares are currently sold short. Is Clearside Biomedical's short interest increasing or decreasing? Clearside Biomedical saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 468,900 shares, a drop of 36.3% from the previous total of 735,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Clearside Biomedical's short interest compare to its competitors? 0.68% of Clearside Biomedical's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Clearside Biomedical: Candel Therapeutics, Inc. (12.93%), Aurora Cannabis Inc. (9.02%), Astria Therapeutics, Inc. (6.16%), Compass Therapeutics, Inc. (8.20%), Bright Minds Biosciences Inc. (2.03%), Monopar Therapeutics Inc. (1.32%), Nuvectis Pharma, Inc. (13.46%), Lifecore Biomedical, Inc. (7.91%), Y-mAbs Therapeutics, Inc. (10.62%), Acelyrin, Inc. (4.99%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.93 billion), iShares 20+ Year Treasury Bond ETF ($9.31 billion), Strategy Incorporated ($8.42 billion), Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Super Micro Computer, Inc. ($3.98 billion), Capital One Financial Co. ($3.79 billion), TC Energy Co. ($3.43 billion), AppLovin Co. ($2.91 billion), and Schlumberger Limited ($2.89 billion). View all of the most shorted stocks. What does it mean to sell short Clearside Biomedical stock? Short selling CLSD is an investing strategy that aims to generate trading profit from Clearside Biomedical as its price is falling. CLSD shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Clearside Biomedical? A short squeeze for Clearside Biomedical occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CLSD, which in turn drives the price of the stock up even further. How often is Clearside Biomedical's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CLSD, twice per month. The most recent reporting period available is March, 31 2025. More Short Interest Resources from MarketBeat Related Companies Candel Therapeutics Short Squeeze Aurora Cannabis Short Squeeze Astria Therapeutics Short Squeeze Compass Therapeutics Short Squeeze Bright Minds Biosciences Short Squeeze Monopar Therapeutics Short Squeeze Nuvectis Pharma Short Squeeze Lifecore Biomedical Short Squeeze Y-mAbs Therapeutics Short Squeeze Acelyrin Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CLSD) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clearside Biomedical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Clearside Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CLSD Stock Free CLSD Stock Alerts